| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191370 | Annals of Allergy, Asthma & Immunology | 2014 | 7 Pages |
Abstract
Sulfasalazine is a highly effective treatment for patients with antihistamine resistant CIU. The frequency of adverse events leading to an alteration of sulfasalazine treatment supports the need for close monitoring of these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Roy Anthony MD, Hersha Timble, Sarbjit S. MD,